UEBER DIO BIOVERFUEGBARKEIT BEI GELAGERTEN SUPPOSITORIEN: UNTERSUCHUNGEN AM BEISPIEL DES NAPROXEN. II: ZUR BIOVERFUEGBARKEIT DES NAPROXEN BEI GELAGERTEN SUPPOSITORIEN = LA BIODISPONIBILITE DES SUPPOSITOIRES STOCKES: RECHERCHES D'APRES L'EXEMPLE DU NAPROXENE. II: LA BIODISPONIBILITE DU NAPROXENE DANS LES SUPPOSITOIRES ENTREPOSESECKERT T; KNIE U; VAN HUSEN N et al.1982; PHARMAZEUTISCHE INDUSTRIE; ISSN 0031-711X; DEU; DA. 1982; VOL. 44; NO 9; PP. 927-929; ABS. ENG; BIBL. 12 REF.Article

A METHOD TO PREDICT INFINITY VALUES FOR BIEXPONENTIAL PROCESSESNEWBURGER J; WAGNER JG; STAVCHANSKY S et al.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 4; PP. 417-425; BIBL. 9 REF.Article

THE SCIENTIFIC BASIS OF BIOAVAILABILITY.RITSCHEL WA.1978; LABO-PHARMA, PROBL. TECH.; FR.; DA. 1978; VOL. 26; NO 276; PP. 395-404; ABS. FR.; BIBL. 22 REF.Article

BIODISPONIBILITE DES MEDICAMENTS ET EQUIVALENCE GENERIQUE.JAMINET F.1977; J. PHARM. BELG.; BELG.; DA. 1977; VOL. 32; NO 4; PP. 325-346; ABS. NEERL. ANGL.; BIBL. 17 REF.Article

BIOSYNTHETIC LABELING OF DIPHTHAMIDE IN SACCHAROMYUS CEREVISIAEDUNLOP PC; BODLEY YW.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 8; PP. 4754-4758; BIBL. 17 REF.Article

MODELISATION MATHEMATIQUE DES PROCESSUS DE PHARMACOCINETIQUE ET SON APPLICATION PRATIQUE POSSIBLEDYACHINA EG.1978; BIOFIZIKA; SUN; DA. 1978; VOL. 23; NO 6; PP. 1051-1055; ABS. ENG; BIBL. 9 REF.Article

AKTUAL'NYE PROBLEMY BIOFARMATSII: SBORNIK NAUCHNYKH TRUDOV = PROBLEMES ACTUELS DE LA BIOPHARMACIETENTSOVAYA AI.1978; ; SUN; MOSKVA: 1 M.M.I. IM. I.M. SECHENOVA; DA. 1978; 120 P.: ILL.; 20 CM; BIBL. DISSEM.Book

BIODISPONIBILITE ET EFFICACITE DES MEDICAMENTS.SAFAR GJ.1977; PARIS; PYM; DA. 1977; PP. 1-213; BIBL. 7 P. 1/2; (THESE DOCT. PHARM. UNIV.; CLERMONT-FERRAND)Thesis

ETUDE DE LA LIBERATION DE SUBSTANCES ACTIVES SOLUBILISEES A PARTIR DE POMMADES. IV. EFFETS DE QUELQUES SOLVANTS SUR LA LIBERATION DE LA DETREOMYCINE DE POMMADES EMULSIFIANTES FAITES DE PETROLE BLANC ET DE TWEEN 60 A 3%KUBIS A.1977; ACTA POLON. PHARM.; POLOGNE; DA. 1977; VOL. 34; NO 2; PP. 195-201; ABS. RUSSE ANGL.; BIBL. 23 REF.Article

DETECTION OF MYCOPLASMA CONTAMINATION IN LYMPHOBLASTOID CULTURES BY A SIMPLE, HPLC METHODMCENTIRE JE; LEGRAND R; GRINSTEAD G et al.1983; JOURNAL OF LIQUID CHROMATOGRAPHY; ISSN 0148-3919; USA; DA. 1983; VOL. 6; NO 6; PP. 1099-1110; BIBL. 7 REF.Article

MULTIPLE COVALENT MODIFICATIONS OF TRG, A SENSORY TRANSDUCER OF ESCHERICHIA COLIKEHRY MR; ENGSTROM P; DAHLQUIST FW et al.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 8; PP. 5050-5055; BIBL. 27 REF.Article

PLATELET SIZE IN THROMBOCYTOPENIA DUE TO SEPSISBESSMAN JD; GARDNER FH.1983; SURGERY, GYNECOLOGY AND OBSTETRICS; ISSN 0039-6087; USA; DA. 1983; VOL. 156; NO 2; PP. 177-180; BIBL. 12 REF.Article

VERGLEICH DER BIOVERFUEGBARKEIT UND DIURETISCHEN WIRKSAMKEIT ZWEIER FUROSEMID-AEQUIVALENZPRAEPARATE = COMPARAISON DE LA BIODISPONIBILITE ET DE L'ACTION DIURETIQUE DE 2 PREPARATIONS EQUIVALENTES DE FUROSEMIDEDANON A; KAPLANSKI J.1979; THERAPIEWOCHE; DEU; DA. 1979; VOL. 29; NO 11; PP. 1887-1888; BIBL. 3 REF.Article

COMPRIMES DE DIGOXINE, UN EXEMPLE D'AMELIORATION DE LA BIODISPONIBILITELECHEVIN JC; BIELA K.1978; BULL. TRAV. SOC. PHARM. LYON; FRA; DA. 1978 PUBL. 1980; VOL. 22; NO 3-4; PP. 49-57; BIBL. 8 REF.Article

DETERMINATION DE LA PERMEABILITE DIFFUSE DES ENVELOPPES DES MICRO-CAPSULESAL'TSHULER MA; GORBENKO SI; APOSTALYUK ZS et al.1981; NEFTEPERERAB. NEFTEHIM.; ISSN 0548-1406; UKR; DA. 1981; NO 20; PP. 68-70; BIBL. 4 REF.Article

PRESYSTEMIC DRUG ELIMINATIONROUTLEDGE PA; SHAND DG.1979; ANNU. REV. PHARMACOL. TOXICOL.; USA; DA. 1979; NO 19; PP. 447-468; BIBL. 121 REF.Article

SYMPOSIUM ON BIOAVAILABILITY AND CLINICAL PHARMACOKINETICS.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 10 PART. 2; PP. 539-576; BIBL. DISSEM.; (ANNU. MEET. AM. COLL. CLIN. PHARMACOL. 5. PROC.; PHILADELPHIA; 1976)Conference Paper

SEQUENTIAL FIRST-PASS ELIMINATION OF A METABOLITE DERIVED FROM A PRECURSORPANG KS; GILLETTE JR.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 3; PP. 275-290; BIBL. 13 REF.Article

RELATIVE BIOVERFUEGBARKEIT EINER NEUEN SPIRONOLACTON-ZUBEREITUNG = BIODISPONIBILITE RELATIVE D'UNE NOUVELLE PREPARATION DE SPIRONOLACTONEERKING W; LUECKER PW; STOECKER KP et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 8; PP. 1184-1189; ABS. ENG; BIBL. 8 REF.Article

DIE BIOLOGISCHE VERFUEGBARKEIT VON DIGITOXIN. = LA DISPONIBILITE BIOLOGIQUE DE LA DIGITOXINEVOEHRINGER HF; LEOPOLD G; RIETBROCK N et al.1978; FORTSCHR. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 2; PP. 71Article

SYMPOSIUM ON BIOEQUIVALENCE: CLINICAL, PHARMACEUTICAL AND ECONOMIC IMPLICATIONS. STOCKHOLM NOVEMBER 9-10, 19771978; ACTA PHARM. SUECICA; SWE; DA. 1978; VOL. 15; NO 4; PP. 291-319; BIBL. DISSEM.Article

THEOPHYLLINE BIOAVAILABILITY FOLLOWING ORAL ADMINISTRATION OF SIX SUSTAINED-RELEASE PREPARATIONS.SPANGLER DL; KALOF DD; BLOOM FL et al.1978; ANN. ALLERGY; U.S.A.; DA. 1978; VOL. 40; NO 1; PP. 6-11; BIBL. 19 REF.Article

ASSESSMENT OF 75/75 RULE: FDA VIEWPOINTCABANA BE.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 1; PP. 98-99; BIBL. 2 REF.Article

BIOAVAILABILITY OF INDOMETHACIN FROM TWO MULTIPLE-UNITS CONTROLLED RELEASE FORMULATIONSBECHGAARD H; BRODIE RR; CHASSEAUD LF et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 21; NO 6; PP. 511-515; BIBL. 25 REF.Article

DRUG METABOLISM BY THE GASTROINTESTINAL MUCOSAGEORGE CF.1981; CLIN. PHARMACOKINET.; ISSN 0312-5963; AUS; DA. 1981; VOL. 6; NO 4; PP. 259-274; BIBL. 3 P.Article